⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 14, 2024European UrologyOpen Access

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

Fredrik Möller Marianne Månsson Jonas Wallström Mikael Hellström Jonas Hugosson Rebecka Arnsrud Godtman

View Full Paper

Ask AI

Bookmark

Share

Abstract

Magnetic resonance imaging(MRI) and targeted biopsies reduce overdiagnosis of prostate cancer(PC). It is uncertain how this strategy performs for low PSA levels. The objective was to investigate the PI-RADS distribution, frequency and characteristics of screen-detected PC with PSA of 1.8-<3ng/ml and 3-<10ng/ml.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Möller et al. (2024) studied this question.

synapsesocial.com/papers/68e73fdcb6db6435876b961d https://doi.org/10.1016/j.eururo.2024.01.017

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Real‐World Clinical Evaluation of S2,3PSA Test in a Prostate Biopsy Cohort With PSA Level of 4–10 ng/mLOriginal Research · 2026
2Prostate-specific Antigen Density as a Selection Tool Before Magnetic Resonance Imaging in Prostate Cancer Screening: An Analysis from the STHLM3MRI Randomized Clinical TrialRCT · 2025 · 9 citations
3Avoiding unnecessary biopsy in suspicious prostate cancer using PRIMARY score ≤3 and PSAD ≤0.2 ng/mL/cm3: a real-world, dual-center study from ChinaOriginal Research · 2026 · 3 citations
4The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese mencohort · 2023 · 9 citations
5Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy OnlyRandomized Controlled Trial · 2022 · 385 citations

Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study2024
Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening2024
Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation – Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010–20232026
Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE TrialEuropean Urology · 2026
Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial PlatformENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026

More from European Urology

More from University of Gothenburg